PDS Biotechnology ( ($PDSB) ) has shared an update. On June 2, 2025, PDS Biotechnology Corporation announced the publication of three Versamune® ...

BioAtla (BCAB) announced data in a poster titled, “Phase 2 Trial of Ozuriftamab Vedotin, a Conditionally Binding CAB-ROR2-ADC, in Patients with ...

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that ten abstracts have been accepted for presentation at ...

The study abstracts were published on the ASCO website on May 22, 2025 (CDT), with key highlights summarized below: ...

Acceptance of multiple abstracts for presentation at significant medical congresses, showcasing the company’s research on oral bradykinin B2 receptor antagonists and their relevance to treating ...

Abstract: Testing complex systems is crucial for ensuring safety, especially in automated driving, where diverse data sources and variable environments pose challenges. Here, robust safety validation ...

GSK is preparing to present data from its respiratory portfolio in more than 40 abstracts at the 2025 edition of the American Thoracic Society (ATS) International Congress, which will be held in San ...